GTHX - G1 Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

GTHX is currently covered by 6 analysts with an average price target of $18.74. This is a potential upside of $14.27 (319.24%) from yesterday's end of day stock price of $4.47.

G1 Therapeutics's activity chart (see below) currently has 36 price targets and 45 ratings on display. The stock rating distribution of GTHX is 91.3% BUY, 4.35% HOLD and 4.35% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.33% with an average time for these price targets to be met of 64.67 days.

Highest price target for GTHX is $12, Lowest price target is $4, average price target is $18.74.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 28-Feb-2024. First documented stock forecast 12-Jun-2017.

Best performing analysts who are covering GTHX - G1 Therapeutics:

Chad Messer David Nierengarten Anupam Rama Dane Leone Gil Blum Edward White

Currently out of the existing stock ratings of GTHX, 21 are a BUY (91.3%), 1 are a HOLD (4.35%), 1 are a SELL (4.35%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

12

$7.53 (168.46%)

1 months ago

0/3 (0%)

$8.67 (260.36%)

Buy

4

$-0.47 (-10.51%)

5

1 months 15 days ago

2/8 (25%)

$1.9 (90.48%)

51

Buy

11

4 months 26 days ago

0/7 (0%)

$8.76 (391.07%)

Sell

10

5 months 22 days ago

1/5 (20%)

$2.57 (34.59%)

86

Buy

24

$19.53 (436.91%)

1 years 11 months 2 days ago

1/4 (25%)

$18.07 (304.72%)

63

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GTHX (G1 Therapeutics) average time for price targets to be met?

On average it took 64.67 days on average for the stock forecasts to be realized with a an average price target met ratio 18.33

Which analyst has the current highest performing score on GTHX (G1 Therapeutics) with a proven track record?

CHAD MESSER

Which analyst has the current lower performing score on GTHX (G1 Therapeutics) with a proven track record?

EDWARD WHITE

Which analyst has the most public recommendations on GTHX (G1 Therapeutics)?

Chad Messer has 6 price targets and 8 ratings on GTHX

Which analyst is the currently most bullish on GTHX (G1 Therapeutics)?

Chad Messer with highest potential upside - $63.53

Which analyst is the currently most reserved on GTHX (G1 Therapeutics)?

David Nierengarten with lowest potential downside - -$0.47

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?